The role of microRNAs in the pathogenesis of herpesvirus infection

Viruses

Volumn 8, Issue 6, 2016, Pages

  Piedade, Diogo ^a   Azevedo Pereira, José Miguel ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Herpesvirus; Immune evasion; Latency; MicroRNAs; Oncogenesis; Pathogenesis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HSA MICRORNA 106A; HSA MICRORNA 1258; HSA MICRORNA 1293; HSA MICRORNA 132; HSA MICRORNA 142 3P; HSA MICRORNA 146A; HSA MICRORNA 193A; HSA MICRORNA 199A; HSA MICRORNA 221; HSA MICRORNA 222; HSA MICRORNA 223; HSA MICRORNA 23; HSA MICRORNA 27B; HSA MICRORNA 30B; HSA MICRORNA 30C; HSA MICRORNA 31; HSA MICRORNA 320D; HSA MICRORNA 378; HSA MICRORNA 424; HSA MICRORNA 608; HSA MICRORNA LET 7I; KSHV MICRORNA K12 3; KSHV MICRORNA K12 4 3P; KSHV MICRORNA K12 5; MICRORNA; MICRORNA 200B; MICRORNA 429; MICRORNA LET 7A; UNCLASSIFIED DRUG; VIRUS RNA;

ALPHAHERPESVIRINAE; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GAMMAHERPESVIRINAE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; IMMUNE EVASION; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; REVIEW; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS ENTRY; GENE EXPRESSION REGULATION; HERPESVIRIDAE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOLOGY;

GENE EXPRESSION REGULATION; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS;

EID: 84973154870     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8060156     Document Type: Review

References (208)

1. Bushati, N.; Cohen, S. M. microRNA functions. Annu. Rev. Cell. Dev. Biol. 2007, 23, 175-205. [CrossRef] [PubMed]
2. Kloosterman, W. P.; Plasterk, R. H. A. The Diverse Functions of MicroRNAs in Animal Development and Disease. Dev. Cell 2006, 11, 441-450. [CrossRef] [PubMed]
3. Doench, J. G.; Petersen, C. P.; Sharp, P. A. siRNAs can function as miRNAs. Genes Dev. 2003, 17, 438-442. [CrossRef] [PubMed]
4. Bartel, D. P. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 2004, 116, 281-297. [CrossRef]
5. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75, 843-854. [CrossRef]
6. Wightman, B.; Ha, I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75, 855-862. [CrossRef]
7. Valencia-Sanchez, M. A.; Liu, J.; Hannon, G. J.; Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20, 515-524. [CrossRef] [PubMed]
8. Pillai, R. S.; Bhattacharyya, S. N.; Filipowicz, W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell. Biol. 2007, 17, 118-126. [CrossRef] [PubMed]
9. Nilsen, T. W. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 2007, 23, 243-249. [CrossRef] [PubMed]
10. Friedman, R. C.; Farh, K. K.-H.; Burge, C. B.; Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19, 92-105. [CrossRef] [PubMed]
11. Kozomara, A.; Griffiths-Jones, S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014, 42, D68-D73. [CrossRef] [PubMed]
12. Esquela-Kerscher, A.; Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6, 259-269. [CrossRef] [PubMed]
13. Chang, T.-C.; Mendell, J. T. microRNAs in Vertebrate Physiology and Human Disease. Annu. Rev. Genom. Hum. Genet. 2007, 8, 215-239. [CrossRef] [PubMed]
14. Krützfeldt, J.; Stoffel, M. MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab. 2006, 4, 9-12. [CrossRef] [PubMed]
15. Farazi, T. A.; Spitzer, J. I.; Morozov, P.; Tuschl, T. miRNAs in human cancer. J. Pathol. 2011, 223, 102-115. [CrossRef] [PubMed]
16. Lakatos, L.; Szittya, G.; Silhavy, D.; Burgyán, J. Molecular mechanism of RNA silencing suppression mediated by p19 protein of tombusviruses. EMBO J. 2004, 23, 876-884. [CrossRef] [PubMed]
17. Vance, V.; Vaucheret, H. RNA silencing in plants-defense and counterdefense. Science 2001, 292, 2277-2280. [CrossRef] [PubMed]
18. Katze, M. G.; He, Y.; Gale, M., Jr. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002, 2, 675-687. [CrossRef] [PubMed]
19. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411, 494-498. [CrossRef] [PubMed]
20. Cullen, B. R. How Do Viruses Avoid Inhibition by Endogenous Cellular MicroRNAs? PLoS Pathog. 2013, 9, 12-14. [CrossRef] [PubMed]
21. Lu, S.; Cullen, B. R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J. Virol. 2004, 78, 12868-12876. [CrossRef] [PubMed]
22. Bennasser, Y.; Yeung, M. L.; Jeang, K.-T. HIV-1 TAR RNA Subverts RNA Interference in Transfected Cells through Sequestration of TAR RNA-binding Protein, TRBP. J. Biol. Chem. 2006, 281, 27674-27678. [CrossRef] [PubMed]
23. Harwig, A.; Das, A. T.; Berkhout, B. Retroviral microRNAs. Curr. Opin. Virol. 2014, 7, 47-54. [CrossRef] [PubMed]
24. Grundhoff, A.; Sullivan, C. S. Virus-encoded microRNAs. Virology 2011, 411, 325-343. [CrossRef] [PubMed]
25. Luna, J. M.; Scheel, T. K. H.; Rice, C. M.; Darnell, R. B. Hepatitis C Virus RNA Functionally Sequesters miR-122. Cell 2015, 160, 1099-1110. [CrossRef] [PubMed]
26. Lecellier, C. H.; Dunoyer, P.; Arar, K.; Lehmann-Che, J.; Eyquem, S.; Himber, C.; Saib, A.; Voinnet, O. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308, 557-560. [CrossRef] [PubMed]
27. Bai, X. T.; Nicot, C. miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection. J. Biol. Chem. 2015, 290, 5381-5390. [CrossRef] [PubMed]
28. Delorme-Axford, E.; Donker, R. B.; Mouillet, J.-F.; Chu, T.; Bayer, A.; Ouyang, Y.; Wang, T.; Stolz, D. B.; Sarkar, S. N.; Morelli, A. E.; et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc. Natl. Acad. Sci. USA 2013, 110, 12048-12053. [CrossRef] [PubMed]
29. Frappier, L. Regulation of Herpesvirus Reactivation by Host MicroRNAs. J. Virol. 2015, 89, 2456-2458. [CrossRef] [PubMed]
30. Cullen, B. R. Herpesvirus microRNAs: Phenotypes and functions. Curr. Opin. Virol. 2011, 1, 211-215. [CrossRef] [PubMed]
31. Kincaid, R. P.; Sullivan, C. S. Virus-Encoded microRNAs: An Overview and a Look to the Future. PLoS Pathog. 2012, 8, e1003018. [CrossRef] [PubMed]
32. Sun, L.; Li, Q. The miRNAs of herpes simplex virus (HSV). Virol. Sin. 2012, 27, 333-338. [CrossRef] [PubMed]
33. Hook, L.; Hancock, M.; Landais, I.; Grabski, R.; Britt, W.; Nelson, J. A. Cytomegalovirus microRNAs. Curr. Opin. Virol. 2014, 7, 40-46. [CrossRef] [PubMed]
34. Barth, S.; Meister, G.; Grässer, F. A. EBV-encoded miRNAs. Biochim. Biophys. Acta 2011, 1809, 631-640. [CrossRef] [PubMed]
35. Gottwein, E. Kaposi's Sarcoma-Associated Herpesvirus microRNAs. Front. Microbiol. 2012, 3, 165. [CrossRef] [PubMed]
36. Zhu, Y.; Haecker, I.; Yang, Y.; Gao, S.-J.; Renne, R.-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr. Opin. Virol. 2013, 3, 266-275. [CrossRef] [PubMed]
37. Boss, I. W.; Renne, R. Viral miRNAs and immune evasion. Biochim. Biophys. Acta 2011, 1809, 708-714. [CrossRef] [PubMed]
38. Kuzembayeva, M.; Hayes, M.; Sugden, B. Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr. Opin. Virol. 2014, 7, 61-65. [CrossRef] [PubMed]
39. Ziegelbauer, J. M. Functions of Kaposi's sarcoma-associated herpesvirus microRNAs. Biochim. Biophys. Acta 2011, 1809, 623-630. [CrossRef] [PubMed]
40. Lee, Y.; Kim, M.; Han, J.; Yeom, K.-H.; Lee, S.; Baek, S. H.; Kim, V. N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23, 4051-4060. [CrossRef] [PubMed]
41. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294, 853-858. [CrossRef] [PubMed]
42. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Rådmark, O.; Kim, S.; et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425, 415-419. [CrossRef] [PubMed]
43. Lund, E.; Güttinger, S.; Calado, A.; Dahlberg, J. E.; Kutay, U. Nuclear export of microRNA precursors. Science 2004, 303, 95-98. [CrossRef] [PubMed]
44. Bohnsack, M. T.; Czaplinski, K.; Gorlich, D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10, 185-191. [CrossRef] [PubMed]
45. Yi, R.; Qin, Y.; Macara, I. G.; Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17, 3011-3016. [CrossRef] [PubMed]
46. Bernstein, E.; Caudy, A. A.; Hammond, S. M.; Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001, 409, 363-366. [CrossRef] [PubMed]
47. Hutvágner, G.; McLachlan, J.; Pasquinelli, A. E.; Bálint, E.; Tuschl, T.; Zamore, P. D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293, 834-838. [CrossRef] [PubMed]
48. Zamore, P. D.; Tuschl, T.; Sharp, P. A.; Bartel, D. P. RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000, 101, 25-33. [CrossRef]
49. Chekulaeva, M.; Filipowicz, W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell. Biol. 2009, 21, 452-460. [CrossRef] [PubMed]
50. Doench, J. G.; Sharp, P. A. Specificity of microRNA target selection in translational repression. Genes Dev. 2004, 18, 504-511. [CrossRef] [PubMed]
51. Brennecke, J.; Stark, A.; Russell, R. B.; Cohen, S. M. Principles of microRNA-target recognition. PLoS Biol. 2005, 3, 404-418. [CrossRef] [PubMed]
52. Larsson, O.; Nadon, R. Re-analysis of genome wide data on mammalian microRNA-mediated suppression of gene expression. Translation 2013, 1, e24557/1-e24557/9. [CrossRef] [PubMed]
53. Djuranovic, S.; Nahvi, A.; Green, R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012, 336, 237-240. [CrossRef] [PubMed]
54. Bazzini, A. A.; Lee, M. T.; Giraldez, A. J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 2012, 336, 233-237. [CrossRef] [PubMed]
55. Béthune, J.; Artus-Revel, C. G.; Filipowicz, W. Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep. 2012, 13, 716-723. [CrossRef] [PubMed]
56. Fabian, M. R.; Mathonnet, G.; Sundermeier, T.; Mathys, H.; Zipprich, J. T.; Svitkin, Y. V.; Rivas, F.; Jinek, M.; Wohlschlegel, J.; Doudna, J. A.; et al. Mammalian miRNA RISC Recruits CAF1 and PABP to Affect PABP-Dependent Deadenylation. Mol. Cell 2009, 35, 868-880. [CrossRef] [PubMed]
57. Guo, H.; Ingolia, N. T.; Weissman, J. S.; Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466, 835-840. [CrossRef] [PubMed]
58. Du, T.; Han, Z.; Zhou, G.; Roizman, B. Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation. Proc. Natl. Acad. Sci. USA 2015, 112, E49-E55. [CrossRef] [PubMed]
59. Wagner, E. K.; Devi-Rao, G.; Feldman, L. T.; Dobson, A. T.; Zhang, Y. F.; Flanagan, W. M.; Stevens, J. G. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J. Virol. 1988, 62, 1194-1202. [PubMed]
60. Randall, G.; Lagunoff, M.; Roizman, B. Herpes simplex virus 1 open reading frames O and P are not necessary for establishment of latent infection in mice. J. Virol. 2000, 74, 9019-9027. [CrossRef] [PubMed]
61. Cui, C.; Griffiths, A.; Li, G.; Silva, L. M.; Kramer, M. F.; Gaasterland, T.; Wang, X.-J.; Coen, D. M. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 2006, 80, 5499-5508. [CrossRef] [PubMed]
62. Tang, S.; Patel, A.; Krause, P. R. Novel Less-Abundant Viral MicroRNAs Encoded by Herpes Simplex Virus 2 Latency-Associated Transcript and Their Roles in Regulating ICP34. 5 and ICP0 mRNAs. J. Virol. 2009, 83, 1433-1442. [CrossRef] [PubMed]
63. Tang, S.; Bertke, A. S.; Patel, A.; Wang, K.; Cohen, J. I.; Krause, P. R. An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34. 5, a viral neurovirulence factor. Proc. Natl. Acad. Sci. USA 2008, 105, 10931-10936. [CrossRef] [PubMed]
64. Umbach, J. L.; Nagel, M. A.; Cohrs, R. J.; Gilden, D. H.; Cullen, B. R. Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J. Virol. 2009, 83, 10677-10683. [CrossRef] [PubMed]
65. Umbach, J. L.; Wang, K.; Tang, S.; Krause, P. R.; Mont, E. K.; Cohen, J. I.; Cullen, B. R. Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2. J. Virol. 2010, 84, 1189-1192. [CrossRef] [PubMed]
66. Jurak, I.; Kramer, M. F.; Mellor, J. C.; van Lint, A. L.; Roth, F. P.; Knipe, D. M.; Coen, D. M. Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J. Virol. 2010, 84, 4659-4672. [CrossRef] [PubMed]
67. Umbach, J. L.; Kramer, M. F.; Jurak, I.; Karnowski, H. W.; Coen, D. M.; Cullen, B. R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454, 780-783. [CrossRef] [PubMed]
68. Wu, W.; Guo, Z.; Zhang, X.; Guo, L.; Liu, L.; Liao, Y.; Wang, J.; Wang, L.; Li, Q. A microRNA encoded by HSV-1 inhibits a cellular transcriptional repressor of viral immediate early and early genes. Sci. China Life Sci. 2013, 56, 373-383. [CrossRef] [PubMed]
69. Munson, D. J.; Burch, A. D. A novel miRNA produced during lytic HSV-1 infection is important for efficient replication in tissue culture. Arch. Virol. 2012, 157, 1677-1688. [CrossRef] [PubMed]
70. Duan, F.; Liao, J.; Huang, Q.; Nie, Y.; Wu, K. HSV-1 miR-H6 Inhibits HSV-1 Replication and IL-6 Expression in Human Corneal Epithelial Cells In Vitro. Clin. Dev. Immunol. 2012, 2012, 1-8. [CrossRef] [PubMed]
71. Tang, S.; Bertke, A. S.; Patel, A.; Margolis, T. P.; Krause, P. R. Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype. J. Virol. 2011, 85, 4501-4509. [CrossRef] [PubMed]
72. Samaniego, L. A.; Wu, N.; DeLuca, N. A. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 1997, 71, 4614-4625. [PubMed]
73. Zheng, S.; Li, Y.; Zhang, Y.; Li, X.; Tang, H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antivir. Res. 2011, 89, 219-226. [CrossRef] [PubMed]
74. Ru, J.; Sun, H.; Fan, H.; Wang, C.; Li, Y.; Liu, M.; Tang, H. MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. PLoS ONE 2014, 9, e114021. [CrossRef] [PubMed]
75. Hill, J. M.; Zhao, Y.; Clement, C.; Neumann, D. M.; Lukiw, W. J. HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. NeuroReport 2009, 20, 1500-1505. [CrossRef] [PubMed]
76. Varani, S.; Landini, M. Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2011, 2, 6. [CrossRef] [PubMed]
77. Ng, K. R.; Li, J. Y.; Gleadle, J. M. Human cytomegalovirus encoded microRNAs: Hitting targets. Expert Rev. Anti-Infect. Ther. 2015, 13, 1469-1479. [CrossRef] [PubMed]
78. Pfeffer, S.; Sewer, A.; Lagos-Quintana, M.; Sheridan, R.; Sander, C.; Grässer, F. A.; van Dyk, L. F.; Ho, C. K.; Shuman, S.; Chien, M.; et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2, 269-276. [CrossRef] [PubMed]
79. Grey, F.; Antoniewicz, A.; Allen, E.; Saugstad, J.; McShea, A.; Carrington, J. C.; Nelson, J. Identification and characterization of human cytomegalovirus-encoded microRNAs. J. Virol. 2005, 79, 12095-12099. [CrossRef] [PubMed]
80. Dunn, W.; Trang, P.; Zhong, Q.; Yang, E.; van Belle, C.; Liu, F. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell. Microbiol. 2005, 7, 1684-1695. [CrossRef] [PubMed]
81. Stark, T. J.; Arnold, J. D.; Spector, D. H.; Yeo, G. W. High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection. J. Virol. 2012, 86, 226-235. [CrossRef] [PubMed]
82. Stern-Ginossar, N.; Elefant, N.; Zimmermann, A.; Wolf, D. G.; Saleh, N.; Biton, M.; Horwitz, E.; Prokocimer, Z.; Prichard, M.; Hahn, G.; et al. Host immune system gene targeting by a viral miRNA. Science 2007, 317, 376-381. [CrossRef] [PubMed]
83. Nachmani, D.; Lankry, D.; Wolf, D. G.; Mandelboim, O. The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat. Immunol. 2010, 11, 806-813. [CrossRef] [PubMed]
84. Huang, Y.; Qi, Y.; Ma, Y.; He, R.; Ji, Y.; Sun, Z.; Ruan, Q. The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1. J. Virol. 2013, 10, 51. [CrossRef] [PubMed]
85. Esteso, G.; Luzon, E.; Sarmiento, E.; Gomez-Caro, R.; Steinle, A.; Murphy, G.; Carbone, J.; Vales-Gomez, M.; Reyburn, H. T. Altered MicroRNA Expression after Infection with Human Cytomegalovirus Leads to TIMP3 Downregulation and Increased Shedding of Metalloprotease Substrates, Including MICA. J. Immunol. 2014, 193, 1344-1352. [CrossRef] [PubMed]
86. Kim, Y.; Lee, S.; Kim, S.; Kim, D.; Ahn, J.-H.; Ahn, K. Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog. 2012, 8, e1002577. [CrossRef] [PubMed]
87. Maghazachi, A. A.; Al-Aoukaty, A.; Schall, T. J. CC chemokines induce the generation of killer cells from CD56+ cells. Eur. J. Immunol. 1996, 26, 315-319. [CrossRef] [PubMed]
88. Landais, I.; Pelton, C.; Streblow, D.; DeFilippis, V.; McWeeney, S.; Nelson, J. A. Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway. PLoS Pathog. 2015, 11, e1004881. [CrossRef] [PubMed]
89. + T cell responses by targeting the aminopeptidase ERAP1. Nat. Immunol. 2011, 12, 984-991. [CrossRef] [PubMed]
90. Noriega, V.; Redmann, V.; Gardner, T.; Tortorella, D. Diverse immune evasion strategies by human cytomegalovirus. Immunol. Res. 2012, 54, 140-151. [CrossRef] [PubMed]
91. Grey, F.; Meyers, H.; White, E. A.; Spector, D. H.; Nelson, J. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog. 2007, 3, 1593-1602. [CrossRef] [PubMed]
92. Grey, F.; Tirabassi, R.; Meyers, H.; Wu, G.; McWeeney, S.; Hook, L.; Nelson, J. A. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog. 2010, 6, e1000967. [CrossRef] [PubMed]
93. Qi, M.; Qi, Y.; Ma, Y.; He, R.; Ji, Y.; Sun, Z.; Ruan, Q. Over-expression of human cytomegalovirus miR-US25-2-3p downregulates eIF4A1 and inhibits HCMV replication. FEBS Lett. 2013, 587, 2266-2271. [CrossRef] [PubMed]
94. Pavelin, J.; Reynolds, N.; Chiweshe, S.; Wu, G.; Tiribassi, R.; Grey, F. Systematic MicroRNA Analysis Identifies ATP6V0C as an Essential Host Factor for Human Cytomegalovirus Replication. PLoS Pathog. 2013, 9, 1-13. [CrossRef] [PubMed]
95. Hook, L. M.; Grey, F.; Grabski, R.; Tirabassi, R.; Doyle, T.; Hancock, M.; Landais, I.; Jeng, S.; McWeeney, S.; Britt, W.; et al. Cytomegalovirus miRNAs Target Secretory Pathway Genes to Facilitate Formation of the Virion Assembly Compartment and Reduce Cytokine Secretion. Cell Host Microbe 2014, 15, 363-373. [CrossRef] [PubMed]
96. Murphy, E.; Vanicek, J.; Robins, H.; Shenk, T.; Levine, A. J. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: Implications for latency. Proc. Natl. Acad. Sci. USA 2008, 105, 5453-5458. [CrossRef] [PubMed]
97. Stern-Ginossar, N.; Saleh, N.; Goldberg, M. D.; Prichard, M.; Wolf, D. G.; Mandelboim, O. Analysis of human cytomegalovirus-encoded microRNA activity during infection. J. Virol. 2009, 83, 10684-10693. [CrossRef] [PubMed]
98. Tirabassi, R.; Hook, L.; Landais, I.; Grey, F.; Meyers, H.; Hewitt, H.; Nelson, J. Human Cytomegalovirus US7 Is Regulated Synergistically by Two Virally Encoded MicroRNAs and by Two Distinct Mechanisms. J. Virol. 2011, 85, 11938-11944. [CrossRef] [PubMed]
99. Huang, Y.; Qi, Y.; Ma, Y.; He, R.; Ji, Y.; Sun, Z.; Ruan, Q. Down-regulation of human cytomegalovirus UL138, a novel latency-associated determinant, by hcmv-miR-UL36. J. Biosci. 2013, 38, 479-485. [CrossRef] [PubMed]
100. Meshesha, M. K.; Bentwich, Z.; Solomon, S. A.; Avni, Y. S. In vivo expression of human cytomegalovirus (HCMV) microRNAs during latency. Gene 2016, 575, 101-107. [CrossRef] [PubMed]
101. Fu, M.; Gao, Y.; Zhou, Q.; Zhang, Q.; Peng, Y.; Tian, K.; Wang, J.; Zheng, X. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA. Gene 2014, 536, 272-278. [CrossRef] [PubMed]
102. Fu, Y.-R.; Liu, X.-J.; Li, X.-J.; Shen, Z.-Z.; Yang, B.; Wu, C.-C.; Li, J.-F.; Miao, L.-F.; Ye, H.-Q.; Qiao, G.-H.; et al. miR-21 Attenuates Human Cytomegalovirus Replication in Neural Cells by Targeting Cdc25a. J. Virol. 2014, 89, 1070-1082. [CrossRef] [PubMed]
103. Luo, M. H.; Hannemann, H.; Kulkarni, A. S.; Schwartz, P. H.; O'Dowd, J. M.; Fortunato, E. A. Human Cytomegalovirus Infection Causes Premature and Abnormal Differentiation of Human Neural Progenitor Cells. J. Virol. 2010, 84, 3528-3541. [CrossRef] [PubMed]
104. Wang, F.; Weber, F.; Croce, C.; Liu, C.; Liao, X.; Pellett, P. E. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J. Virol. 2008, 82, 9065-9074. [CrossRef] [PubMed]
105. O'Connor, C. M.; Vanicek, J.; Murphy, E. A. Host miRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency. J. Virol. 2014, 88, 5524-5532.
106. Lisboa, L. F.; Egli, A.; O'Shea, D.; Åsberg, A.; Hartmann, A.; Rollag, H.; Pang, X. L.; Tyrrell, D. L.; Kumar, D.; Humar, A. Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications. Am. J. Transpl. 2015, 15, 1893-1902. [CrossRef] [PubMed]
107. Thi, E. P.; Mire, C. E.; Lee, A. C. H.; Geisbert, J. B.; Zhou, J. Z.; Agans, K. N.; Snead, N. M.; Deer, D. J.; Barnard, T. R.; Fenton, K. A.; et al. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature 2015, 521, 362-365. [CrossRef] [PubMed]
108. Janssen, H. L. A. A.; Reesink, H. W.; Lawitz, E. J.; Zeuzem, S.; Rodriguez-Torres, M.; Patel, K.; van der Meer, A. J.; Patick, A. K.; Chen, A.; Zhou, Y.; et al. Treatment of HCV Infection by Targeting MicroRNA. N. Engl. J. Med. 2013, 368, 1685-1694. [CrossRef] [PubMed]
109. Thorley-Lawson, D. A.; Hawkins, J. B.; Tracy, S. I.; Shapiro, M. The pathogenesis of Epstein-Barr virus persistent infection. Curr. Opin. Virol. 2013, 3, 227-232. [CrossRef] [PubMed]
110. Delecluse, H.-J.; Feederle, R.; O'Sullivan, B.; Taniere, P. Epstein Barr virus-associated tumours: An update for the attention of the working pathologist. J. Clin. Pathol. 2007, 60, 1358-1364. [CrossRef] [PubMed]
111. Murata, T.; Sato, Y.; Kimura, H. Modes of infection and oncogenesis by the Epstein-Barr virus. Rev. Med. Virol. 2014, 24, 242-253. [CrossRef] [PubMed]
112. Pratt, Z. L.; Kuzembayeva, M.; Sengupta, S.; Sugden, B. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 2009, 386, 387-397. [CrossRef] [PubMed]
113. Cai, X.; Schäfer, A.; Lu, S.; Bilello, J. P.; Desrosiers, R. C.; Edwards, R.; Raab-Traub, N.; Cullen, B. R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2, e23. [CrossRef] [PubMed]
114. Cosmopoulos, K.; Pegtel, M.; Hawkins, J.; Moffett, H.; Novina, C.; Middeldorp, J.; Thorley-Lawson, D. A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 2009, 83, 2357-2367. [CrossRef] [PubMed]
115. Grundhoff, A. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12, 733-750. [CrossRef] [PubMed]
116. Landgraf, P.; Rusu, M.; Sheridan, R.; Sewer, A.; Iovino, N.; Aravin, A.; Pfeffer, S.; Rice, A.; Kamphorst, A. O.; Landthaler, M.; et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129, 1401-1414. [CrossRef] [PubMed]
117. Lung, R. W.-M.; Tong, J. H.-M.; Sung, Y.-M.; Leung, P.-S.; Ng, D. C.-H.; Chau, S.-L.; Chan, A. W.-H.; Ng, E. K.-O.; Lo, K.-W.; To, K.-F. Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22. Neoplasia 2009, 11, 1174-IN17. [CrossRef] [PubMed]
118. Pfeffer, S.; Zavolan, M.; Grässer, F. A.; Chien, M.; Russo, J. J.; Ju, J.; John, B.; Enright, A. J.; Marks, D.; Sander, C.; et al. Identification of virus-encoded microRNAs. Science 2004, 304, 734-736. [CrossRef] [PubMed]
119. Zhu, J. Y.; Pfuhl, T.; Motsch, N.; Barth, S.; Nicholls, J.; Grasser, F.; Meister, G. Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas. J. Virol. 2009, 83, 3333-3341. [CrossRef] [PubMed]
120. Lo, A. K. F.; To, K. F.; Lo, K. W.; Lung, R. W. M.; Hui, J. W. Y.; Liao, G.; Hayward, S. D. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl. Acad. Sci. USA 2007, 104, 16164-16169. [CrossRef] [PubMed]
121. Xia, T.; O'Hara, A.; Araujo, I.; Barreto, J.; Carvalho, E.; Sapucaia, J. B.; Ramos, J. C.; Luz, E.; Pedroso, C.; Manrique, M.; et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008, 68, 1436-1442. [CrossRef] [PubMed]
122. Marquitz, A. R.; Mathur, A.; Nam, C. S.; Raab-Traub, N. The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology 2011, 412, 392-400. [CrossRef] [PubMed]
123. Vereide, D. T.; Seto, E.; Chiu, Y.-F.; Hayes, M.; Tagawa, T.; Grundhoff, A.; Hammerschmidt, W.; Sugden, B. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 2014, 33, 1258-1264. [CrossRef] [PubMed]
124. Nachmani, D.; Stern-Ginossar, N.; Sarid, R.; Mandelboim, O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009, 5, 376-385. [CrossRef] [PubMed]
125. Lei, T.; Yuen, K.-S.; Xu, R.; Tsao, S. W.; Chen, H.; Li, M.; Kok, K.-H.; Jin, D.-Y. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int. J. Cancer 2013, 133, 79-87. [CrossRef] [PubMed]
126. Choy, E. Y.-W.; Siu, K.-L.; Kok, K.-H.; Lung, R. W.-M.; Tsang, C. M.; To, K.-F.; Kwong, D. L.-W.; Tsao, S. W.; Jin, D.-Y. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 2008, 205, 2551-2560. [CrossRef] [PubMed]
127. Godshalk, S.; Bhaduri-McIntosh, S.; Slack, F. J. Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle 2008, 7, 3595-3600. [CrossRef] [PubMed]
128. Iizasa, H.; Wulff, B.-E.; Alla, N. R.; Maragkakis, M.; Megraw, M.; Hatzigeorgiou, A.; Iwakiri, D.; Takada, K.; Wiedmer, A.; Showe, L.; et al. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 2010, 285, 33358-33370. [CrossRef] [PubMed]
129. Wong, A. M. G.; Kong, K. L.; Tsang, J. W. H.; Kwong, D. L. W.; Guan, X.-Y. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2012, 118, 698-710. [CrossRef] [PubMed]
130. Haneklaus, M.; Gerlic, M.; Kurowska-Stolarska, M.; Rainey, A.-A.; Pich, D.; McInnes, I. B.; Hammerschmidt, W.; O'Neill, L. A. J.; Masters, S. L. Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1 Production. J. Immunol. 2012, 189, 3795-3799. [CrossRef] [PubMed]
131. Kim, H.; Choi, H.; Lee, S. K. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD. Cancer Lett. 2015, 356, 733-742. [CrossRef] [PubMed]
132. Mansouri, S.; Pan, Q.; Blencowe, B. J.; Claycomb, J. M.; Frappier, L. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer. J. Virol. 2014, 88, 11166-11177. [CrossRef] [PubMed]
133. Ellis-Connell, A. L.; Iempridee, T.; Xu, I.; Mertz, J. E. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J. Virol. 2010, 84, 10329-10343. [CrossRef] [PubMed]
134. Lin, Z.; Wang, X.; Fewell, C.; Cameron, J.; Yin, Q.; Flemington, E. K. Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429. J. Virol. 2010, 84, 7892-7897. [CrossRef] [PubMed]
135. Klinke, O.; Feederle, R.; Delecluse, H. J. Genetics of Epstein-Barr virus microRNAs. Semin. Cancer Biol. 2014, 26, 52-59. [CrossRef] [PubMed]
136. Kraus, R. J.; Perrigoue, J. G.; Mertz, J. E. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 2003, 77, 199-207. [CrossRef] [PubMed]
137. Ellis, A. L.; Wang, Z.; Yu, X.; Mertz, J. E. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J. Virol. 2010, 84, 6139-6152. [CrossRef] [PubMed]
138. Gatto, G.; Rossi, A.; Rossi, D.; Kroening, S.; Bonatti, S.; Mallardo, M. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway. Nucleic Acids Res. 2008, 36, 6608-6619. [CrossRef] [PubMed]
139. Cameron, J. E.; Fewell, C.; Yin, Q.; McBride, J.; Wang, X.; Lin, Z.; Flemington, E. K. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 2008, 382, 257-266. [CrossRef] [PubMed]
140. Linnstaedt, S. D.; Gottwein, E.; Skalsky, R. L.; Luftig, M. A.; Cullen, B. R. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 2010, 84, 11670-11678. [CrossRef] [PubMed]
141. Chen, S.-J.; Chen, G.-H.; Chen, Y.-H.; Liu, C.-Y.; Chang, K.-P.; Chang, Y.-S.; Chen, H.-C. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS ONE 2010, 5, e12745. [CrossRef] [PubMed]
142. Kim, D. N.; Chae, H.-S.; Oh, S. T.; Kang, J.-H.; Park, C. H.; Park, W. S.; Takada, K.; Lee, J. M.; Lee, W.-K.; Lee, S. K. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J. Virol. 2007, 81, 1033-1036. [CrossRef] [PubMed]
143. Marquitz, A. R.; Mathur, A.; Chugh, P. E.; Dittmer, D. P.; Raab-Traub, N. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J. Virol. 2014, 88, 1389-1393. [CrossRef] [PubMed]
144. Imig, J.; Motsch, N.; Zhu, J. Y.; Barth, S.; Okoniewski, M.; Reineke, T.; Tinguely, M.; Faggioni, A.; Trivedi, P.; Meister, G.; et al. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 2011, 39, 1880-1893. [CrossRef] [PubMed]
145. Amoroso, R.; Fitzsimmons, L.; Thomas, W. A.; Kelly, G. L.; Rowe, M.; Bell, A. I. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J. Virol. 2011, 85, 996-1010. [CrossRef] [PubMed]
146. Motsch, N.; Alles, J.; Imig, J.; Zhu, J.; Barth, S.; Reineke, T.; Tinguely, M.; Cogliatti, S.; Dueck, A.; Meister, G.; et al. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS ONE 2012, 7, e42193. [CrossRef] [PubMed]
147. Cai, L.-M.; Lyu, X.-M.; Luo, W.-R.; Cui, X.-F.; Ye, Y.-F.; Yuan, C.-C.; Peng, Q.-X.; Wu, D.-H.; Liu, T.-F.; Wang, E.; et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 2015, 34, 2156-2166. [CrossRef] [PubMed]
148. Cai, L.; Ye, Y.; Jiang, Q.; Chen, Y.; Lyu, X.; Li, J.; Wang, S.; Liu, T.; Cai, H.; Yao, K.; et al. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Nat. Commun. 2015, 6, 7353. [CrossRef] [PubMed]
149. Kanda, T.; Miyata, M.; Kano, M.; Kondo, S.; Yoshizaki, T.; Iizasa, H. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J. Virol. 2015, 89, 2684-2697. [CrossRef] [PubMed]
150. Pegtel, D. M.; Cosmopoulos, K.; Thorley-Lawson, D. A.; van Eijndhoven, M. A. J.; Hopmans, E. S.; Lindenberg, J. L.; de Gruijl, T. D.; Wurdinger, T.; Middeldorp, J. M. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 2010, 107, 6328-6333. [CrossRef] [PubMed]
151. Meckes, D. G.; Shair, K. H. Y.; Marquitz, A. R.; Kung, C.-P.; Edwards, R. H.; Raab-Traub, N. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. USA 2010, 107, 20370-20375. [CrossRef] [PubMed]
152. Gourzones, C.; Gelin, A.; Bombik, I.; Klibi, J.; Vérillaud, B.; Guigay, J.; Lang, P.; Témam, S.; Schneider, V.; Amiel, C.; et al. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. J. Virol. 2010, 7, 271. [CrossRef] [PubMed]
153. Ascherio, A.; Munger, K. L. Epstein-Barr Virus Infection and Multiple Sclerosis: A Review. J. Neuroimmune Pharmacol. 2010, 5, 271-277. [CrossRef] [PubMed]
154. Handel, A. E.; Williamson, A. J.; Disanto, G.; Handunnetthi, L.; Giovannoni, G.; Ramagopalan, S. V. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS ONE 2010, 5, 1-5. [CrossRef] [PubMed]
155. Levin, L. I.; Munger, K. L.; O'Reilly, E. J.; Falk, K. I.; Ascherio, A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 2010, 67, 824-830. [CrossRef] [PubMed]
156. Pohl, D. Epstein-Barr virus and multiple sclerosis. J. Neurol. Sci. 2009, 286, 62-64. [CrossRef] [PubMed]
157. Thacker, E. L.; Mirzaei, F.; Ascherio, A. Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann. Neurol. 2006, 59, 499-503. [CrossRef] [PubMed]
158. Qin, Z.; Jakymiw, A.; Findlay, V.; Parsons, C. KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts. Int. J. Cell Biol. 2012, 2012, 1-9. [CrossRef] [PubMed]
159. Cai, X.; Lu, S.; Zhang, Z.; Gonzalez, C. M.; Damania, B.; Cullen, B. R. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. USA 2005, 102, 5570-5575. [CrossRef] [PubMed]
160. Samols, M. A.; Hu, J.; Skalsky, R. L.; Renne, R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2005, 79, 9301-9305. [CrossRef] [PubMed]
161. Marshall, V.; Parks, T.; Bagni, R.; Wang, C. D.; Samols, M. A.; Hu, J.; Wyvil, K. M.; Aleman, K.; Little, R. F.; Yarchoan, R.; et al. Conservation of virally encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J. Infect. Dis 2007, 195, 645-659. [PubMed]
162. Umbach, J. L.; Cullen, B. R. In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J. Virol. 2010, 84, 695-703. [CrossRef] [PubMed]
163. Marshall, V.; Martró, E.; Labo, N.; Ray, A.; Wang, D.; Mbisa, G.; Bagni, R. K.; Volfovsky, N.; Casabona, J.; Whitby, D. Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study. J. Infect. Dis 2010, 202, 1126-1135. [CrossRef] [PubMed]
164. Gottwein, E.; Cullen, B. R. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J. Virol. 2010, 84, 5229-5237. [CrossRef] [PubMed]
165. Lei, X.; Bai, Z.; Ye, F.; Xie, J.; Kim, C.-G.; Huang, Y.; Gao, S.-J. Regulation of NF-κB inhibitor IκBα and viral replication by a KSHV microRNA. Nat. Cell. Biol. 2010, 12, 193-199. [CrossRef] [PubMed]
166. Lei, X.; Zhu, Y.; Jones, T.; Bai, Z.; Huang, Y.; Gao, S.-J. A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival. J. Virol. 2012, 86, 11698-11711. [CrossRef] [PubMed]
167. Suffert, G.; Malterer, G.; Hausser, J.; Viiliäinen, J.; Fender, A.; Contrant, M.; Ivacevic, T.; Benes, V.; Gros, F.; Voinnet, O.; et al. Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog. 2011, 7, e1002405. [CrossRef] [PubMed]
168. Qin, Z.; Freitas, E.; Sullivan, R.; Mohan, S.; Bacelieri, R.; Branch, D.; Romano, M.; Kearney, P.; Oates, J.; Plaisance, K.; et al. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 2010, 6, e1000742. [CrossRef] [PubMed]
169. Hansen, A.; Henderson, S.; Lagos, D.; Nikitenko, L.; Coulter, E.; Roberts, S.; Gratrix, F.; Plaisance, K.; Renne, R.; Bower, M.; et al. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 2010, 24, 195-205. [CrossRef] [PubMed]
170. Skalsky, R. L.; Samols, M. A.; Plaisance, K. B.; Boss, I. W.; Riva, A.; Lopez, M. C.; Baker, H. V.; Renne, R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 2007, 81, 12836-12845. [CrossRef] [PubMed]
171. Gottwein, E.; Mukherjee, N.; Sachse, C.; Frenzel, C.; Majoros, W. H.; Chi, J.-T. A.; Braich, R.; Manoharan, M.; Soutschek, J.; Ohler, U.; et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450, 1096-1099. [CrossRef] [PubMed]
172. Lu, C.-C.; Li, Z.; Chu, C.-Y.; Feng, J.; Feng, J.; Sun, R.; Rana, T. M. MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep. 2010, 11, 784-790. [CrossRef] [PubMed]
173. Lu, F.; Stedman, W.; Yousef, M.; Renne, R.; Lieberman, P. M. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 2010, 84, 2697-2706. [CrossRef] [PubMed]
174. Ziegelbauer, J. M.; Sullivan, C. S.; Ganem, D. Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat. Genet. 2009, 41, 130-134. [CrossRef] [PubMed]
175. Abend, J. R.; Ramalingam, D.; Kieffer-Kwon, P.; Uldrick, T. S.; Yarchoan, R.; Ziegelbauer, J. M. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J. Virol. 2012, 86, 11663-11674. [CrossRef] [PubMed]
176. Lin, X.; Liang, D.; He, Z.; Deng, Q.; Robertson, E. S.; Lan, K. miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS ONE 2011, 6, e16224. [CrossRef] [PubMed]
177. Bellare, P.; Ganem, D. Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation. Cell Host Microbe 2009, 6, 570-575. [CrossRef] [PubMed]
178. Abend, J. R.; Uldrick, T.; Ziegelbauer, J. M. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J. Virol. 2010, 84, 12139-12151. [CrossRef] [PubMed]
179. Liang, D.; Gao, Y.; Lin, X.; He, Z.; Zhao, Q.; Deng, Q.; Lan, K. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKK". Cell Res. 2011, 21, 793-806. [CrossRef] [PubMed]
180. Boss, I. W.; Nadeau, P. E.; Abbott, J. R.; Yang, Y.; Mergia, A.; Renne, R. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rnull mice. J. Virol. 2011, 85, 9877-9886. [CrossRef] [PubMed]
181. Liu, Y.; Sun, R.; Lin, X.; Liang, D.; Deng, Q.; Lan, K. Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J. Virol. 2012, 86, 1372-1381. [CrossRef] [PubMed]
182. Moody, R.; Zhu, Y.; Huang, Y.; Cui, X.; Jones, T.; Bedolla, R.; Lei, X.; Bai, Z.; Gao, S.-J. KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog. 2013, 9, e1003857. [CrossRef] [PubMed]
183. Gottwein, E.; Corcoran, D. L.; Mukherjee, N.; Skalsky, R. L.; Hafner, M.; Nusbaum, J. D.; Shamulailatpam, P.; Love, C. L.; Dave, S. S.; Tuschl, T.; et al. Viral MicroRNA Targetome of KSHV-Infected Primary Effusion Lymphoma Cell Lines. Cell Host Microbe 2011, 10, 515-526. [CrossRef] [PubMed]
184. Manzano, M.; Shamulailatpam, P.; Raja, A. N.; Gottwein, E. Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23. J. Virol. 2013, 87, 11821-11830. [CrossRef] [PubMed]
185. Mashima, R. Physiological roles of miR-155. Immunology 2015, 145, 323-333. [CrossRef] [PubMed]
186. Qin, Z.; Peruzzi, F.; Reiss, K.; Dai, L. Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis. Viruses 2014, 6, 4571-4580. [CrossRef] [PubMed]
187. Tsai, Y.-H.; Wu, M.-F.; Wu, Y.-H.; Chang, S.-J.; Lin, S.-F.; Sharp, T. V.; Wang, H.-W. The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J. Virol. 2009, 83, 622-632. [CrossRef] [PubMed]
188. Wu, Y.-H.; Hu, T.-F.; Chen, Y.-C.; Tsai, Y.-N.; Tsai, Y.-H.; Cheng, C.-C.; Wang, H.-W. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 2011, 118, 2896-2905. [CrossRef] [PubMed]
189. Bridge, G.; Monteiro, R.; Henderson, S.; Emuss, V.; Lagos, D.; Georgopoulou, D.; Patient, R.; Boshoff, C. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood 2012, 120, 5063-5072. [CrossRef] [PubMed]
190. Punj, V.; Matta, H.; Schamus, S.; Tamewitz, A.; Anyang, B.; Chaudhary, P. M. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 2010, 29, 1835-1844. [CrossRef] [PubMed]
191. Kang, J.-G.; Majerciak, V.; Uldrick, T. S.; Wang, X.; Kruhlak, M.; Yarchoan, R.; Zheng, Z.-M. Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J. Pathol. 2011, 225, 378-389. [CrossRef] [PubMed]
192. Kang, J.-G.; Pripuzova, N.; Majerciak, V.; Kruhlak, M.; Le, S.-Y.; Zheng, Z.-M. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J. Virol. 2011, 85, 2620-2630. [CrossRef] [PubMed]
193. Lagos, D.; Pollara, G.; Henderson, S.; Gratrix, F.; Fabani, M.; Milne, R. S. B.; Gotch, F.; Boshoff, C. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 2010, 12, 513-519. [CrossRef] [PubMed]
194. Yan, Q.; Ma, X.; Shen, C.; Cao, X.; Feng, N.; Qin, D.; Zeng, Y.; Zhu, J.; Gao, S.-J.; Lu, C. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258. J. Virol. 2014, 88, 4987-5000. [CrossRef] [PubMed]
195. Yan, Q.; Li, W.; Tang, Q.; Yao, S.; Lv, Z.; Feng, N.; Ma, X.; Bai, Z.; Zeng, Y.; Qin, D.; et al. Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA. PLoS ONE 2013, 8, e55832. [CrossRef] [PubMed]
196. Shin, C.; Nam, J.-W.; Farh, K. K.-H.; Chiang, H. R.; Shkumatava, A.; Bartel, D. P. Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell 2010, 38, 789-802. [CrossRef] [PubMed]
197. Lim, L. P.; Lau, N. C.; Garrett-Engele, P.; Grimson, A.; Schelter, J. M.; Castle, J.; Bartel, D. P.; Linsley, P. S.; Johnson, J. M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433, 769-773. [CrossRef] [PubMed]
198. Dölken, L.; Malterer, G.; Erhard, F.; Kothe, S.; Friedel, C. C.; Suffert, G.; Marcinowski, L.; Motsch, N.; Barth, S.; Beitzinger, M.; et al. Systematic Analysis of Viral and Cellular MicroRNA Targets in Cells Latently Infected with Human-Herpesviruses by RISC Immunoprecipitation Assay. Cell Host Microbe 2010, 7, 324-334. [CrossRef] [PubMed]
199. Haecker, I.; Gay, L. A.; Yang, Y.; Hu, J.; Morse, A. M.; McIntyre, L. M.; Renne, R. Ago HITS-CLIP Expands Understanding of Kaposi's Sarcoma-associated Herpesvirus miRNA Function in Primary Effusion Lymphomas. PLoS Pathog. 2012, 8, e1002884. [CrossRef] [PubMed]
200. Riley, K. J.; Rabinowitz, G. S.; Yario, T. A.; Luna, J. M.; Darnell, R. B.; Steitz, J. A. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012, 31, 2207-2221. [CrossRef] [PubMed]
201. Skalsky, R. L.; Corcoran, D. L.; Gottwein, E.; Frank, C. L.; Kang, D.; Hafner, M.; Nusbaum, J. D.; Feederle, R.; Delecluse, H. J.; Luftig, M. A.; et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012, 8. [CrossRef] [PubMed]
202. Gallaher, A. M.; Das, S.; Xiao, Z.; Andresson, T.; Kieffer-Kwon, P.; Happel, C.; Ziegelbauer, J. Proteomic Screening of Human Targets of Viral microRNAs Reveals Functions Associated with Immune Evasion and Angiogenesis. PLoS Pathog. 2013, 9, e1002484. [CrossRef] [PubMed]
203. Lee, S. H.; Kalejta, R. F.; Kerry, J.; Semmes, O. J.; O'Connor, C. M.; Khan, Z.; Garcia, B. A.; Shenk, T.; Murphy, E. BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2012, 109, 9575-9580. [CrossRef] [PubMed]
204. Grosswendt, S.; Filipchyk, A.; Manzano, M.; Klironomos, F.; Schilling, M.; Herzog, M.; Gottwein, E.; Rajewsky, N. Unambiguous Identification of miRNA: Target site interactions by different types of ligation reactions. Mol. Cell 2014, 54, 1042-1054. [CrossRef] [PubMed]
205. Helwak, A.; Tollervey, D. Mapping the miRNA interactome by cross-linking ligation and sequencing of hybrids (CLASH). Nat. Protoc. 2014, 9, 711-728. [CrossRef] [PubMed]
206. Feldman, E. R.; Kara, M.; Coleman, C. B.; Grau, K. R.; Oko, L. M.; Krueger, B. J.; Renne, R.; van Dyk, L. F.; Tibbetts, S. A. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio 2014, 5, e00981-14. [CrossRef] [PubMed]
207. Yu, Z. H.; Teng, M.; Sun, A. J.; Yu, L. L.; Hu, B.; Qu, L. H.; Ding, K.; Cheng, X. C.; Liu, J. X.; Cui, Z. Z.; et al. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus. Virology 2014, 448, 55-64. [CrossRef] [PubMed]
208. Kramer, M. F.; Jurak, I.; Pesola, J. M.; Boissel, S.; Knipe, D. M.; Coen, D. M. Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia. Virology 2011, 417, 239-247. [CrossRef] [PubMed]